Index -
P/E -
EPS (ttm) -1.14
Insider Own 1.04%
Shs Outstand 181.36M
Perf Week -2.03%
Market Cap 10.84B
Forward P/E 505.87
EPS next Y 0.12
Insider Trans -5.34%
Shs Float 179.65M
Perf Month -10.70%
Income -204.15M
PEG -
EPS next Q -0.48
Inst Own 87.63%
Short Float 5.51%
Perf Quarter -7.09%
Sales 2.50B
P/S 4.34
EPS this Y 19.50%
Inst Trans -1.74%
Short Ratio 4.01
Perf Half Y -3.38%
Book/sh 17.34
P/B 3.44
EPS next Y 112.98%
ROA -3.00%
Short Interest 9.89M
Perf Year -4.72%
Cash/sh 4.28
P/C 13.94
EPS next 5Y -
ROE -6.60%
52W Range 56.05 - 100.77
Perf YTD -19.27%
Dividend Est. -
P/FCF 339.54
EPS past 5Y 4.59%
ROI -3.63%
52W High -40.73%
Beta 1.26
Dividend TTM -
Quick Ratio 2.07
Sales past 5Y 43.88%
Gross Margin 70.14%
52W Low 6.55%
ATR (14) 3.05
Dividend Ex-Date -
Current Ratio 2.32
EPS Y/Y TTM 67.92%
Oper. Margin -12.20%
RSI (14) 38.49
Volatility 4.44% 4.85%
Employees 6600
Debt/Eq 0.82
Sales Y/Y TTM 19.93%
Profit Margin -8.17%
Recom 1.32
Target Price 90.49
Option/Short Yes / Yes
LT Debt/Eq 0.79
EPS Q/Q 61.80%
Payout -
Rel Volume 0.70
Prev Close 58.79
Sales Surprise 1.26%
EPS Surprise 36.16%
Sales Q/Q 16.98%
Earnings May 08 AMC
Avg Volume 2.47M
Price 59.72
SMA20 -11.83%
SMA50 -5.72%
SMA200 -15.04%
Trades
Volume 317,486
Change 1.59%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-02-24 Upgrade
The Benchmark Company
Hold → Buy
$91
Dec-14-23 Initiated
Guggenheim
Buy
$90
Dec-13-23 Initiated
Wolfe Research
Outperform
$95
Oct-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$90
Sep-28-23 Initiated
Bernstein
Outperform
$83
Aug-02-23 Downgrade
The Benchmark Company
Buy → Hold
May-10-23 Upgrade
Craig Hallum
Hold → Buy
$55 → $85
May-05-23 Initiated
UBS
Neutral
$73
Mar-09-23 Upgrade
Citigroup
Neutral → Buy
$70 → $90
Feb-10-23 Downgrade
Credit Suisse
Outperform → Neutral
$50 → $70
Jan-18-23 Downgrade
Raymond James
Outperform → Mkt Perform
Oct-19-22 Downgrade
Craig Hallum
Buy → Hold
$60 → $35
Aug-25-22 Initiated
Credit Suisse
Outperform
$55
Jun-03-22 Initiated
Piper Sandler
Neutral
$50
Nov-03-21 Downgrade
Raymond James
Strong Buy → Outperform
$160 → $130
Jul-29-21 Reiterated
Stifel
Buy
$165 → $145
Jul-29-21 Reiterated
Oppenheimer
Outperform
$161 → $155
Jul-29-21 Reiterated
Canaccord Genuity
Buy
$185 → $160
Jul-29-21 Reiterated
BTIG Research
Buy
$155 → $145
Jun-15-21 Initiated
Raymond James
Strong Buy
$160
Show Previous Ratings
Apr-25-24 08:05PM
(Morningstar Research) -7.04%
Apr-24-24 06:15PM
07:16AM
Apr-22-24 12:44PM
11:10AM
06:15PM
Loading…
Apr-17-24 06:15PM
Apr-15-24 06:52AM
06:00AM
Apr-12-24 07:00AM
06:49AM
06:40AM
Apr-11-24 06:00AM
Apr-10-24 06:15PM
08:16AM
12:00AM
07:37AM
Loading…
Apr-09-24 07:37AM
Apr-08-24 12:05PM
07:00AM
(The Wall Street Journal)
06:00AM
Apr-05-24 10:16AM
Apr-04-24 10:15AM
06:05AM
Apr-03-24 09:57AM
Apr-02-24 04:02PM
(Investor's Business Daily)
Mar-29-24 08:09AM
Mar-28-24 06:00AM
Mar-27-24 08:05AM
Mar-26-24 07:00AM
Mar-25-24 09:55AM
Mar-22-24 11:30AM
08:19AM
Loading…
Mar-18-24 08:19AM
04:30AM
Mar-14-24 04:16PM
(Investor's Business Daily)
Mar-13-24 05:03PM
Mar-11-24 12:59AM
Mar-08-24 09:55AM
Mar-07-24 07:59AM
Mar-04-24 11:52PM
03:49PM
10:38AM
Mar-03-24 10:32AM
Feb-26-24 06:00AM
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
(Thomson Reuters StreetEvents)
10:22AM
01:30AM
12:06AM
Feb-21-24 06:20PM
05:41PM
(Associated Press Finance)
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
(Morningstar Research) +8.39%
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
(Morningstar Research) -5.09%
Nov-06-23 09:35AM
Nov-03-23 08:09PM
(Morningstar Research) +7.30%
Nov-02-23 07:23PM
04:02PM
(Investor's Business Daily)
11:03AM
09:40AM
(Thomson Reuters StreetEvents)
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
Oct-31-23 05:20PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Baranick Brian EVP, GM., Precision Oncology Apr 02 '24 Sale 79.43 924 73,393 13,171 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Apr 01 '24 Sale 70.00 2,000 140,000 71,787 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Mar 28 '24 Sale 70.00 2,000 140,000 73,787 Apr 01 04:30 PM Conroy Kevin T President and CEO Mar 01 '24 Sale 59.32 8,271 490,636 1,299,496 Mar 04 08:38 PM LEVANGIE DANIEL J Director Mar 01 '24 Sale 57.50 5,000 287,500 22,975 Mar 04 08:42 PM Cunningham Everett Chief Commercial Officer Mar 01 '24 Sale 59.32 2,412 143,080 46,179 Mar 04 08:38 PM Elliott Jeffrey Thomas Chief Financial Officer Mar 01 '24 Sale 59.32 2,412 143,080 10,933 Mar 04 08:40 PM Baranick Brian Gen. Mgr., Precision Oncology Mar 01 '24 Sale 59.32 2,323 137,800 14,095 Mar 04 08:36 PM ORVILLE JACOB A General Manager, Screening Mar 01 '24 Sale 59.32 2,154 127,775 14,324 Mar 04 08:42 PM Doyle James Edward Director Mar 01 '24 Sale 57.50 2,000 115,000 50,110 Mar 04 08:39 PM Condella Sarah EVP, Human Resources Mar 01 '24 Sale 59.32 1,724 102,268 75,787 Mar 04 08:37 PM Herriott James General Counsel Mar 01 '24 Sale 59.32 862 51,134 9,125 Mar 04 08:41 PM Herriott James General Counsel Feb 29 '24 Option Exercise 0.00 1,890 0 9,987 Mar 04 08:41 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 13,345 Mar 04 08:40 PM Cunningham Everett Chief Commercial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 48,591 Mar 04 08:38 PM Conroy Kevin T President and CEO Feb 29 '24 Option Exercise 0.00 18,143 0 1,307,767 Mar 04 08:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 29 '24 Option Exercise 0.00 4,724 0 16,418 Mar 04 08:36 PM Condella Sarah EVP, Human Resources Feb 29 '24 Option Exercise 0.00 3,779 0 77,511 Mar 04 08:37 PM ORVILLE JACOB A General Manager, Screening Feb 29 '24 Option Exercise 0.00 4,724 0 16,478 Mar 04 08:42 PM Conroy Kevin T President and CEO Feb 27 '24 Sale 56.89 6,263 356,302 1,289,624 Feb 28 07:35 PM Cunningham Everett Chief Commercial Officer Feb 27 '24 Sale 56.89 3,648 207,535 43,300 Feb 28 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 27 '24 Sale 56.89 2,710 154,172 8,054 Feb 28 07:36 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 27 '24 Sale 56.89 2,027 115,316 11,694 Feb 28 07:34 PM Condella Sarah EVP, Human Resources Feb 27 '24 Sale 56.89 1,880 106,953 73,732 Feb 28 07:35 PM ORVILLE JACOB A General Manager, Screening Feb 27 '24 Sale 56.89 1,879 106,896 11,754 Feb 28 07:38 PM Herriott James General Counsel Feb 27 '24 Sale 56.89 784 44,602 8,097 Feb 28 07:38 PM ORVILLE JACOB A General Manager, Screening Feb 26 '24 Option Exercise 0.00 3,954 0 13,633 Feb 28 07:38 PM Cunningham Everett Chief Commercial Officer Feb 26 '24 Option Exercise 0.00 7,678 0 46,948 Feb 28 07:37 PM Herriott James General Counsel Feb 26 '24 Option Exercise 0.00 1,648 0 8,881 Feb 28 07:38 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 26 '24 Option Exercise 0.00 5,701 0 10,764 Feb 28 07:36 PM Condella Sarah EVP, Human Resources Feb 26 '24 Option Exercise 0.00 3,954 0 75,612 Feb 28 07:35 PM Conroy Kevin T President and CEO Feb 26 '24 Option Exercise 0.00 13,181 0 1,295,887 Feb 28 07:35 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 26 '24 Option Exercise 0.00 3,954 0 13,721 Feb 28 07:34 PM Conroy Kevin T President and CEO Feb 23 '24 Option Exercise 13.96 102,837 1,435,605 1,344,266 Feb 26 05:00 PM Condella Sarah EVP, Human Resources Feb 23 '24 Sale 59.72 1,021 60,974 71,658 Feb 26 05:00 PM Conroy Kevin T President and CEO Feb 22 '24 Sale 59.78 11,565 691,356 1,241,429 Feb 23 07:59 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 22 '24 Sale 59.78 1,351 80,763 5,063 Feb 23 08:01 PM Cunningham Everett Chief Commercial Officer Feb 22 '24 Sale 59.78 1,350 80,703 39,270 Feb 23 08:00 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 22 '24 Sale 59.78 1,093 65,340 9,767 Feb 23 07:57 PM ORVILLE JACOB A General Manager, Screening Feb 22 '24 Sale 59.78 1,013 60,557 9,679 Feb 23 08:03 PM Condella Sarah EVP, Human Resources Feb 22 '24 Sale 59.78 1,013 60,557 72,679 Feb 23 07:57 PM COWARD D SCOTT Director Feb 22 '24 Sale 59.78 663 39,634 44,493 Feb 23 07:59 PM Herriott James General Counsel Feb 22 '24 Sale 59.78 291 17,396 7,233 Feb 23 08:02 PM Conroy Kevin T President and CEO Feb 21 '24 Sale 61.50 4,975 305,962 1,229,756 Feb 22 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 21 '24 Sale 61.50 1,493 91,820 3,703 Feb 22 07:38 PM Condella Sarah EVP, Human Resources Feb 21 '24 Sale 61.50 1,079 66,358 71,658 Feb 22 07:36 PM ORVILLE JACOB A General Manager, Screening Feb 21 '24 Sale 61.50 1,078 66,297 8,658 Feb 22 07:40 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 21 '24 Sale 61.50 895 55,042 8,826 Feb 22 07:36 PM COWARD D SCOTT Director Feb 21 '24 Sale 61.50 706 43,419 43,122 Feb 22 07:38 PM Herriott James General Counsel Feb 21 '24 Sale 61.50 415 25,522 6,943 Feb 22 07:39 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 20 '24 Option Exercise 0.00 3,112 0 5,196 Feb 22 07:38 PM Conroy Kevin T President and CEO Feb 20 '24 Option Exercise 0.00 10,374 0 1,234,731 Feb 22 07:37 PM COWARD D SCOTT Director Feb 20 '24 Option Exercise 0.00 2,248 0 43,828 Feb 22 07:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 20 '24 Option Exercise 0.00 1,729 0 9,721 Feb 22 07:36 PM Condella Sarah EVP, Human Resources Feb 20 '24 Option Exercise 0.00 2,248 0 72,737 Feb 22 07:36 PM Herriott James General Counsel Feb 20 '24 Option Exercise 0.00 864 0 7,358 Feb 22 07:39 PM ORVILLE JACOB A General Manager, Screening Feb 20 '24 Option Exercise 0.00 2,248 0 9,736 Feb 22 07:40 PM Conroy Kevin T President and CEO Feb 15 '24 Sale 61.43 14,791 908,611 1,224,357 Feb 16 06:22 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 15 '24 Sale 61.43 1,888 115,980 2,084 Feb 16 06:24 PM COWARD D SCOTT Director Feb 15 '24 Sale 61.43 1,376 84,528 41,580 Feb 16 06:23 PM ORVILLE JACOB A General Manager, Screening Feb 15 '24 Sale 61.43 966 59,341 7,488 Feb 16 06:26 PM Condella Sarah EVP, Human Resources Feb 15 '24 Sale 61.43 965 59,280 70,489 Feb 16 06:21 PM Herriott James General Counsel Feb 15 '24 Sale 61.43 421 25,862 6,494 Feb 16 06:25 PM Conroy Kevin T President and CEO Feb 14 '24 Option Exercise 0.00 31,133 0 1,239,148 Feb 16 06:22 PM Condella Sarah EVP, Human Resources Feb 14 '24 Option Exercise 0.00 2,031 0 71,454 Feb 16 06:21 PM Herriott James General Counsel Feb 14 '24 Option Exercise 0.00 883 0 6,915 Feb 16 06:25 PM ORVILLE JACOB A General Manager, Screening Feb 14 '24 Option Exercise 0.00 2,031 0 8,454 Feb 16 06:26 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 14 '24 Option Exercise 0.00 3,972 0 3,972 Feb 16 06:24 PM COWARD D SCOTT Director Feb 14 '24 Option Exercise 0.00 3,972 0 42,956 Feb 16 06:23 PM Condella Sarah EVP, Human Resources Jan 02 '24 Sale 73.50 2,000 147,000 69,423 Jan 04 05:19 PM Baranick Brian Gen. Mgr., Precision Oncology Jan 02 '24 Sale 73.50 879 64,606 7,992 Jan 04 05:17 PM Condella Sarah EVP, Human Resources Dec 14 '23 Sale 70.00 2,000 140,000 71,423 Dec 18 07:49 PM Cunningham Everett Chief Commercial Officer Oct 12 '23 Sale 66.49 13,007 864,835 37,909 Oct 13 07:59 PM Cunningham Everett Chief Commercial Officer Oct 11 '23 Option Exercise 0.00 27,504 0 50,916 Oct 13 07:59 PM Condella Sarah EVP, Human Resources Sep 01 '23 Sale 84.36 4,500 379,620 75,814 Sep 06 04:04 PM Elliott Jeffrey Thomas Chief Financial Officer Aug 21 '23 Sale 82.92 30,210 2,505,013 0 Aug 23 04:08 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 07 '23 Sale 85.04 1,350 114,804 8,871 Aug 08 04:09 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 04 '23 Option Exercise 0.00 2,712 0 10,221 Aug 08 04:09 PM Doyle James Edward Director Jul 27 '23 Sale 97.42 2,000 194,840 52,110 Jul 28 04:06 PM Herriott James General Counsel Jul 19 '23 Sale 100.00 1,300 130,000 5,964 Jul 21 04:04 PM Zanotti Katherine S Director Jun 09 '23 Sale 90.51 3,027 273,974 64,629 Jun 12 04:17 PM Doyle James Edward Director Jun 09 '23 Sale 90.51 1,402 126,895 54,110 Jun 12 04:29 PM Herriott James General Counsel Jun 08 '23 Sale 90.00 1,300 117,000 7,264 Jun 12 04:14 PM Doyle James Edward Director May 26 '23 Sale 80.62 2,000 161,240 51,913 May 31 04:13 PM Condella Sarah EVP, Human Resources May 10 '23 Sale 80.00 6,087 486,960 80,314 May 12 04:11 PM ORVILLE JACOB A General Manager, Screening May 10 '23 Sale 80.00 5,000 400,000 6,423 May 12 04:09 PM Herriott James General Counsel May 10 '23 Sale 79.85 1,300 103,805 8,564 May 12 04:07 PM Condella Sarah EVP, Human Resources May 01 '23 Sale 63.78 1,000 63,780 86,401 May 03 04:04 PM
Index -
P/E 5.40
EPS (ttm) 1.41
Insider Own 5.92%
Shs Outstand 1.10B
Perf Week 4.53%
Market Cap 8.39B
Forward P/E 6.64
EPS next Y 1.15
Insider Trans 0.00%
Shs Float 1.04B
Perf Month 1.46%
Income 1.56B
PEG 0.26
EPS next Q 0.14
Inst Own 81.88%
Short Float 4.51%
Perf Quarter 17.23%
Sales 6.52B
P/S 1.29
EPS this Y -16.60%
Inst Trans -4.35%
Short Ratio 3.32
Perf Half Y 7.17%
Book/sh 5.35
P/B 1.43
EPS next Y 105.50%
ROA 12.50%
Short Interest 46.78M
Perf Year 57.76%
Cash/sh 0.02
P/C 399.67
EPS next 5Y 21.00%
ROE 30.49%
52W Range 4.57 - 7.69
Perf YTD 16.34%
Dividend Est. 0.02 (0.30%)
P/FCF 24.26
EPS past 5Y 8.75%
ROI 15.66%
52W High -0.91%
Beta 1.15
Dividend TTM -
Quick Ratio 0.82
Sales past 5Y 42.40%
Gross Margin 17.89%
52W Low 66.74%
ATR (14) 0.16
Dividend Ex-Date Apr 18, 2000
Current Ratio 0.82
EPS Y/Y TTM -16.28%
Oper. Margin 11.28%
RSI (14) 65.43
Volatility 2.62% 2.28%
Employees 1165
Debt/Eq 0.70
Sales Y/Y TTM -56.53%
Profit Margin 23.87%
Recom 2.57
Target Price 8.27
Option/Short Yes / Yes
LT Debt/Eq 0.69
EPS Q/Q -122.74%
Payout 0.00%
Rel Volume 0.56
Prev Close 7.65
Sales Surprise 31.13%
EPS Surprise 29.18%
Sales Q/Q -49.94%
Earnings May 02 AMC
Avg Volume 14.08M
Price 7.62
SMA20 2.12%
SMA50 5.96%
SMA200 13.52%
Trades
Volume 1,451,375
Change -0.39%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-19-24 Downgrade
Piper Sandler
Overweight → Neutral
$8 → $7
Apr-11-24 Downgrade
Scotiabank
Sector Outperform → Sector Perform
$9.50
Feb-26-24 Upgrade
Mizuho
Underperform → Neutral
$6 → $9
Jan-31-24 Downgrade
Seaport Research Partners
Buy → Neutral
Jan-23-24 Downgrade
Stifel
Buy → Hold
$8.50 → $6.60
Jan-03-24 Downgrade
Mizuho
Neutral → Underperform
$6
Dec-11-23 Upgrade
Citigroup
Neutral → Buy
$8
Dec-06-23 Upgrade
JP Morgan
Underweight → Neutral
$7 → $8.50
Nov-22-23 Upgrade
Wells Fargo
Underweight → Equal Weight
Nov-10-23 Upgrade
Wolfe Research
Underperform → Outperform
$8
Jun-30-23 Initiated
Stifel
Buy
$7.50
May-24-23 Downgrade
Goldman
Neutral → Sell
$5.75 → $5
Apr-19-23 Initiated
UBS
Neutral
$5
Apr-11-23 Downgrade
Wells Fargo
Equal Weight → Underweight
$6 → $5
Apr-10-23 Initiated
Siebert Williams Shank
Hold
$6
Feb-06-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-25-23 Initiated
Wells Fargo
Equal Weight
Jan-23-23 Downgrade
The Benchmark Company
Buy → Hold
Jan-10-23 Downgrade
Mizuho
Buy → Neutral
$11 → $9
Dec-07-22 Downgrade
Citigroup
Buy → Neutral
$10 → $6.50
Show Previous Ratings
Apr-25-24 10:01AM
09:55AM
Apr-17-24 04:42PM
12:32PM
Apr-12-24 11:09AM
06:36AM
Loading…
Apr-05-24 06:36AM
06:12AM
Apr-04-24 12:10PM
Mar-28-24 01:59PM
Mar-03-24 11:33PM
Mar-02-24 10:45AM
Feb-26-24 09:27AM
Feb-23-24 03:30AM
Feb-22-24 07:00PM
06:25PM
05:37PM
Loading…
05:37PM
(Associated Press Finance)
05:32PM
05:08PM
12:02AM
Feb-21-24 11:32AM
Feb-15-24 05:06PM
10:00AM
Feb-12-24 12:10PM
Jan-25-24 04:06AM
Jan-15-24 09:39AM
Jan-12-24 05:32PM
(The Wall Street Journal)
10:15AM
Jan-11-24 06:31PM
05:17PM
04:05PM
(Investor's Business Daily)
03:20PM
Loading…
03:20PM
03:00PM
(The Wall Street Journal)
01:26PM
12:57PM
(The Wall Street Journal)
10:30AM
10:20AM
(The Wall Street Journal)
10:06AM
06:49AM
06:24AM
(The Wall Street Journal)
06:10AM
06:08AM
06:03AM
06:00AM
Jan-10-24 11:10AM
Jan-08-24 08:48AM
06:44AM
Jan-05-24 05:18PM
(Yahoo Finance Video) +7.34%
04:24PM
(The Wall Street Journal)
03:37PM
03:34PM
03:30PM
(The Wall Street Journal)
03:26PM
Jan-02-24 11:00PM
Dec-22-23 02:58PM
Dec-12-23 02:16PM
Dec-01-23 09:30AM
Nov-29-23 03:41PM
Nov-28-23 02:39AM
Nov-27-23 10:33AM
Nov-26-23 11:08AM
Nov-24-23 02:18PM
Nov-15-23 06:08PM
Nov-13-23 10:16PM
Nov-07-23 09:02AM
Nov-06-23 12:27PM
Nov-05-23 01:44PM
Nov-04-23 01:25AM
(Thomson Reuters StreetEvents)
Nov-02-23 06:30PM
06:19PM
05:12PM
(Associated Press Finance)
04:18PM
Nov-01-23 09:30AM
Oct-31-23 10:01AM
Oct-26-23 10:02AM
Oct-25-23 12:17PM
Oct-23-23 12:10PM
Oct-21-23 06:38AM
Oct-19-23 06:55AM
Oct-18-23 04:25PM
07:15AM
Oct-17-23 03:36PM
(Yahoo Finance Video) +8.27%
Sep-07-23 09:00AM
Aug-16-23 04:29PM
Aug-15-23 09:09PM
Aug-07-23 06:47PM
Aug-05-23 02:12AM
(Thomson Reuters StreetEvents)
Aug-04-23 09:04AM
Aug-03-23 09:30PM
06:35PM
05:32PM
04:21PM
Aug-01-23 06:25PM
02:30PM
10:00AM
Jul-25-23 09:00AM
Jul-17-23 03:47PM
Jul-13-23 08:42AM
08:21AM
Jul-10-23 05:22PM
Jul-03-23 09:00AM
Southwestern Energy Co. is a holding company, which engages in the exploration, development, and production of natural gas, oil, and natural gas liquids (NGLs). It operates through the Exploration and Production (E&P), and Marketing segments. The E&P segment includes operations in northeast Pennsylvania, West Virginia, and southwest Pennsylvania, The Marketing segment deals in the marketing and transportation of natural gas, oil and NGLs primarily produced in E&P. The company was founded on July 2, 1929 and is headquartered in Spring, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Huggins Andrew T SVP and Division Head Mar 11 '24 Option Exercise 0.00 11,313 0 207,266 Mar 13 04:08 PM Huggins Andrew T SVP and Division Head Feb 26 '24 Option Exercise 0.00 14,534 0 199,493 Feb 27 04:15 PM Kelly John P SVP and Division Head Feb 26 '24 Option Exercise 0.00 29,066 0 218,115 Feb 27 04:13 PM Cutright Derek W SVP and Division Head Feb 26 '24 Option Exercise 0.00 29,066 0 249,041 Feb 27 04:06 PM Dyson William Q SVP - Operations Services Feb 26 '24 Option Exercise 0.00 29,066 0 195,498 Feb 27 04:18 PM Way William J President and CEO Feb 26 '24 Option Exercise 0.00 280,264 0 3,783,005 Feb 27 04:21 PM Carrell Clayton A. Executive Vice President & COO Feb 26 '24 Option Exercise 0.00 132,867 0 1,451,073 Feb 27 04:23 PM O'Beirne Colin P Vice President and Controller Feb 26 '24 Option Exercise 0.00 18,686 0 171,976 Feb 27 04:28 PM Gillenwater Carina L SVP, Human Resources and Admin Feb 26 '24 Option Exercise 0.00 12,458 0 159,233 Feb 27 04:29 PM Gillenwater Carina L SVP, Human Resources and Admin Feb 23 '24 Option Exercise 0.00 14,844 0 150,390 Feb 27 04:29 PM O'Beirne Colin P Vice President and Controller Feb 23 '24 Option Exercise 0.00 17,177 0 157,473 Feb 27 04:28 PM Lacy Christopher W SVP - General Counsel Feb 23 '24 Option Exercise 0.00 19,087 0 126,268 Feb 27 04:31 PM Carrell Clayton A. Executive Vice President & COO Feb 23 '24 Option Exercise 0.00 97,710 0 1,356,655 Feb 27 04:23 PM Way William J President and CEO Feb 23 '24 Option Exercise 0.00 206,110 0 3,583,846 Feb 27 04:21 PM Dyson William Q SVP - Operations Services Feb 23 '24 Option Exercise 0.00 21,377 0 171,638 Feb 27 04:18 PM Cutright Derek W SVP and Division Head Feb 23 '24 Option Exercise 0.00 21,377 0 225,181 Feb 27 04:06 PM Kelly John P SVP and Division Head Feb 23 '24 Option Exercise 0.00 21,377 0 194,255 Feb 27 04:13 PM Huggins Andrew T SVP and Division Head Feb 23 '24 Option Exercise 0.00 19,087 0 189,607 Feb 27 04:15 PM Gillenwater Carina L SVP, Human Resources and Admin Feb 22 '24 Option Exercise 0.00 14,170 0 138,997 Feb 23 04:15 PM O'Beirne Colin P Vice President and Controller Feb 22 '24 Option Exercise 0.00 15,103 0 143,974 Feb 23 04:18 PM Lacy Christopher W SVP - General Counsel Feb 22 '24 Option Exercise 0.00 26,100 0 113,537 Feb 23 04:18 PM Way William J President and CEO Feb 22 '24 Option Exercise 0.00 218,587 0 3,463,750 Feb 23 04:21 PM Carrell Clayton A. Executive Vice President & COO Feb 22 '24 Option Exercise 0.00 90,420 0 1,294,526 Feb 23 04:08 PM Kelly John P SVP and Division Head Feb 22 '24 Option Exercise 0.00 19,763 0 177,691 Feb 23 04:17 PM Dyson William Q SVP - Operations Services Feb 22 '24 Option Exercise 0.00 19,203 0 154,937 Feb 23 04:13 PM Cutright Derek W SVP and Division Head Feb 22 '24 Option Exercise 0.00 19,763 0 208,617 Feb 23 04:11 PM Huggins Andrew T SVP and Division Head Feb 22 '24 Option Exercise 0.00 17,713 0 174,834 Feb 23 04:16 PM Giesler Carl Fredrick Executive Vice President & CFO Feb 22 '24 Option Exercise 0.00 80,167 0 312,320 Feb 23 04:14 PM Giesler Carl Fredrick Executive Vice President & CFO Feb 21 '24 Option Exercise 0.00 68,683 0 248,878 Feb 23 04:14 PM Cutright Derek W SVP and Division Head Feb 21 '24 Option Exercise 0.00 16,486 0 192,869 Feb 23 04:11 PM Dyson William Q SVP - Operations Services Feb 21 '24 Option Exercise 0.00 15,110 0 139,414 Feb 23 04:13 PM Kelly John P SVP and Division Head Feb 21 '24 Option Exercise 0.00 16,486 0 161,943 Feb 23 04:17 PM Huggins Andrew T SVP and Division Head Feb 21 '24 Option Exercise 0.00 16,486 0 161,136 Feb 23 04:16 PM Carrell Clayton A. Executive Vice President & COO Feb 21 '24 Option Exercise 0.00 71,430 0 1,232,214 Feb 23 04:08 PM Price Dennis SVP - Mktg, Trans & Comm Feb 21 '24 Option Exercise 0.00 25,969 0 25,969 Feb 23 04:20 PM Way William J President and CEO Feb 21 '24 Option Exercise 0.00 224,726 0 3,333,593 Feb 23 04:21 PM Lacy Christopher W SVP - General Counsel Feb 21 '24 Option Exercise 0.00 38,736 0 96,870 Feb 23 04:18 PM O'Beirne Colin P Vice President and Controller Feb 21 '24 Option Exercise 0.00 11,126 0 131,581 Feb 23 04:18 PM Gillenwater Carina L SVP, Human Resources and Admin Feb 21 '24 Option Exercise 0.00 15,110 0 128,507 Feb 23 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite